Skip to main content
Contemporary Clinical Trials Communications logoLink to Contemporary Clinical Trials Communications
. 2023 Feb 8;32:101089. doi: 10.1016/j.conctc.2023.101089

Corrigendum to ‘Decision making for invasive and non-invasive optional procedures within an acute HIV research cohort in Bangkok,’ [Contemporary Clinical Trials Communication (2023)101054]

Sinéad Isaacson a,b, Kristine Kuczynski a, Nuchanart Ormsby a, Holly L Peay c, Stuart Rennie a,d, R Jean Cadigan a,d, Eugène Kroon e, Nittaya Phanuphak e, Jintanat Ananworanich f, Thidarat Jupimai g, Peeriya Prueksakaew e, Gail E Henderson a,∗
PMCID: PMC10025413  PMID: 36949845

The authors regret that Dr. Sandhya Vasan was missed in the author list for this article. The revised author order is as follows:

Sinéad Isaacson1,2, Kristine Kuczynski1, Nuchanart Ormsby1, Holly L. Peay3, Stuart Rennie1,4, R. Jean Cadigan1,4, Eugène Kroon5, Nittaya Phanuphak 5, Jintanat Ananworanich6, Sandhya Vasan7,8, Thidarat Jupimai9, Peeriya Prueksakaew5, Gail E. Henderson1§

1 Social Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

2 Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

3 RTI International, Research Triangle Park, Durham, North Carolina, USA.

4 Center for Bioethics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

5 SEARCH, Institute of HIV Research and Innovation, Bangkok, Thailand.

6 Department of Global Health, Amsterdam University Medical Centers, University of Amsterdam, and Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.

7 US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.

8 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.

9 Center of Excellence in Pediatric Infectious Diseases and Vaccines Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

The authors regret that Acknowledgements omitted reference to cooperative agreements that funded this work, and the Disclaimer was omitted. The corrected versions are as follows.

Disclaimer

The views expressed are those of the authors and should not be construed to represent the positions of the U.S. Army, the Department of Defense, the National Institutes of Health, the Department of Health and Human Services, or the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The investigators have adhered to the policies for protection of human subjects as prescribed in AR-70-25.

Acknowledgements

We thank the participants who contributed their time to this research, as well as the RV254 staff for their assistance. We thank Donn Colby for providing background information on SEARCH010/RV254. The RV254/SEARCH 010, which is supported by cooperative agreements (WW81XWH-18-2-0040) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., United States, and the United States Army Medical Research and Development Command (USAMRDC), United States, and by an intramural grant from the Thai Red Cross AIDS Research Centre and, in part, by the Division of AIDS, the National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States (AAI21058-001-01000). Antiretroviral therapy for RV254/SEARCH 010 participants was supported by the Thai Government Pharmaceutical Organization, Thailand, Gilead Sciences, United States, Merck, United States, and ViiV Healthcare, United Kingdom.

The authors would like to apologise for any inconvenience caused.


Articles from Contemporary Clinical Trials Communications are provided here courtesy of Elsevier

RESOURCES